Daratumumab-based therapies in patients with AL amyloidosis.

被引：0
|
作者：
Abeykoon, Jithma P.
Zanwar, Saurabh
Kumar, Shaji
Dispenzieri, Angela
Rajkumar, S. Vincent
Lacy, Martha
Dingli, David
Leung, Nelson
Muchtar, Eli
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Buadi, Francis
Kyle, Robert A.
Gertz, Morie A.
Kapoor, Prashant
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.8053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8053
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Daratumumab-based therapies in transplant-ineligible patients with untreated multiple myeloma and hepatic dysfunction: A systematic review of subgroup analyses
    David Gil-Sierra, Manuel
    del Pilar Briceno-Casado, Maria
    Fenix-Caballero, Silvia
    Jesus Alegre-Del Rey, Emilio
    Alarcon de la Lastra-Romero, Catalina
    Sanchez-Hidalgo, Marina
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 155 - 161
  • [42] High dose chemotherapy for systemic AL amyloidosis.
    Gillmore, JD
    Apperley, JF
    Pepys, MB
    Hawkins, PN
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2103 - 2103
  • [43] Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens
    De Novellis, Danilo
    Fontana, Raffaele
    Serio, Bianca
    Vaccaro, Emilia
    Guariglia, Roberto
    Morini, Denise
    Rizzo, Michela
    Giudice, Valentina
    Selleri, Carmine
    CANCER MEDICINE, 2024, 13 (14):
  • [44] Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimens
    Phou, Samantha
    Costello, Caitlin
    Kopko, Patricia M.
    Allen, Elizabeth S.
    TRANSFUSION, 2021, 61 (07) : 2054 - 2063
  • [45] The role of renal transplantation in systemic AL amyloidosis.
    Wechalekar, AD
    Lachmann, HJ
    Gillmore, JD
    Goodman, HJB
    Offer, M
    Hawkins, PN
    BLOOD, 2005, 106 (11) : 976A - 977A
  • [46] A single institution review of cases of AL amyloidosis.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Treleaven, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S210 - S210
  • [47] Single institution review of cases of AL amyloidosis.
    Sumpter, K
    Powles, R
    Raje, N
    Kulkarni, S
    Ramiah, V
    Hill, M
    Horton, C
    Milan, S
    Mehta, J
    Singhal, S
    Rodriguez, M
    Mateos, P
    Laufente, A
    Treleaven, J
    BLOOD, 1997, 90 (10) : 4583 - 4583
  • [48] Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA
    Wang, Jiasheng
    Arroyo-Suarez, Raul
    Dasari, Srilatha
    Sekaran, Kanithra
    Tse, William
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1669 - 1677
  • [49] Use of daratumumab in patients with amyloidosis
    Anzai, Adriano
    Utino, Armelin
    Katayama, Haroldo
    Spir, Ighor A. Z.
    Lemos, Marcio A.
    Anhesini, Mauricio
    Tiezzi, Oswaldo S.
    Spir, Patricia R. N.
    Otani, Pericles
    Bernardo, Wanderley M.
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (11): : 1468 - 1471
  • [50] Progress in research: Daratumumab improves treatment outcomes of patients with AL amyloidosis
    Hassan, Hamza
    Anwer, Faiz
    Javaid, Anum
    Hashmi, Hamza
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
12345